Rubén Gil-Gonzalo

Dr. Rubén Gil-Gonzalo

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
RGRubén Gil-Gonzalo
Rubén Gil-Gonzalo
DSDaniel Alonzo Durante Salmerón
Daniel Alonzo Durante Salmerón
SPSaeedeh Pouri
Saeedeh Pouri
Ernesto Doncel-PérezErnesto Doncel-Pérez
Ernesto Doncel-Pérez
Andrés R. AlcántaraAndrés R. Alcántara
Andrés R. Alcántara
NANiuris Acosta
Niuris Acosta
Cancer and bacterial infections rank among the most significant global health threats. accounting for roughly 25 million fatalities each year. This statistic underscores the urgent necessity for developing novel drugs, enhancing current treatments, and implementing systems that boost their bioavailability to achieve superior therapeutic outcomes. Liposomes have been recognised as effective carriers; nonetheless, they encounter issues with long-term stability and structural integrity, which limit their pharmaceutical applicability. Chitosomes (chitosan-coated liposomes) are generally a good alternative to solve these issues. This research aims to demonstrate the effective individual encapsulation of ciprofloxacin (antibacterial, hydrophilic) and etoposide (anticancer, hydrophobic), within chitosomes to create more effective drug delivery systems (oral administration for ciprofloxacin, parenteral administration for etoposide). Thus, liposomes and chitosomes were prepared using the thin-film hydration technique and were characterised through ATR-FTIR, Dynamic Light Scattering (DLS), zeta potential, and release profiling. In both cases, the application of chitosomes enhanced long-term stability in size and surface charge. Chitosome-encapsulated ciprofloxacin formulations exhibited a slower and sustained release profile, while the combined effect of etoposide and chitosan showed heightened efficacy against the glioblastoma cell line U373. Therefore, coating liposomes with chitosan improved the encapsulation system’s properties, resulting in a promising method for drug delivery.

10 June 2024 in Catalysts
Verified
Journal Article
Open access
PDF file
DSDaniel Alonzo Durante Salmerón
Daniel Alonzo Durante Salmerón
IFIsabel Fraile-Gutiérrez
Isabel Fraile-Gutiérrez
RGRubén Gil-Gonzalo
Rubén Gil-Gonzalo
NANiuris Acosta
Niuris Acosta
Inmaculada AranazInmaculada Aranaz
Inmaculada Aranaz
Andrés R. AlcántaraAndrés R. Alcántara
Andrés R. Alcántara
Chitin and chitosan, abundant biopolymers derived from the shells of crustaceans and the cell walls of fungi, have garnered considerable attention in pharmaceutical circles due to their biocompatibility, biodegradability, and versatile properties. Deep eutectic solvents (DESs), emerging green solvents composed of eutectic mixtures of hydrogen bond acceptors and donors, offer promising avenues for enhancing the solubility and functionality of chitin and chitosan in pharmaceutical formulations. This review delves into the potential of utilizing DESs as solvents for chitin and chitosan, highlighting their efficiency in dissolving these polymers, which facilitates the production of novel drug delivery systems, wound dressings, tissue engineering scaffolds, and antimicrobial agents. The distinctive physicochemical properties of DESs, including low toxicity, low volatility, and adaptable solvation power, enable the customization of chitin and chitosan-based materials to meet specific pharmaceutical requirements. Moreover, the environmentally friendly nature of DESs aligns with the growing demand for sustainable and eco-friendly processes in pharmaceutical manufacturing. This revision underscores recent advances illustrating the promising role of DESs in evolving the pharmaceutical applications of chitin and chitosan, laying the groundwork for the development of innovative drug delivery systems and biomedical materials with enhanced efficacy and safety profiles.

28 July 2026 in Applied Biosciences
Verified
Journal Article
Open access
PDF file
RGRubén Gil-Gonzalo
Rubén Gil-Gonzalo
PVPalmira Villa Valverde
Palmira Villa Valverde
Inmaculada AranazInmaculada Aranaz
Inmaculada Aranaz
David CastejonDavid Castejon
David Castejon
In the valorization of organic waste within circular bioeconomy frameworks, compost and insect frass are increasingly used as soil amendments, yet their molecular composition and the metabolic signatures of biological processing remain poorly characterized. In this study, high-resolution magic angle spinning (HRMAS) nuclear magnetic resonance (NMR) was applied to intact compost and frass samples to explore their metabolic profiles and assess the potential of this technique to detect bioindicators of vermi- and insect-associated biotransformation without destructive sample preparation. HRMAS NMR experiments included water-suppressed one-dimensional 1H spectra and selected two-dimensional experiments (1H–13C HSQC and 1H–13C HMBC) to support signal assignment. The analysis revealed clear differences between compost with and without vermicomposting activity, with low-molecular-weight resonances assigned to glycine betaine (betaine), a characteristic metabolite associated with biotransformation. In Tenebrio molitor frass, 1H-HRMAS spectra displayed a distinct set of small-molecule signals, including betaine resonances detected for the first time in this matrix. Time-resolved monitoring showed that betaine signals remained stable during the studied period. These findings demonstrate that HRMAS NMR provides a minimally invasive, versatile platform for direct characterization of compost and frass, supporting the identification of metabolic signatures linked to vermi- and insect-mediated processing.

28 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
RGRubén Gil-Gonzalo
Rubén Gil-Gonzalo
PVPalmira Villa Valverde
Palmira Villa Valverde
Inmaculada AranazInmaculada Aranaz
Inmaculada Aranaz
MCM. Isabel Cambero
M. Isabel Cambero
David CastejonDavid Castejon
David Castejon
The safe use of insect frass as a fertilizer component requires reliable methods to eval-uate hygienization and storage stability in accordance with European regulation. In this study, 1H NMR profiling of aqueous extracts was applied to Tenebrio molitor frass processed under three thermal conditions: no heat treatment, 70 °C for 1 h, and 70 °C for 18 h. Spectra were acquired at 0, 7, and 14 days to monitor compositional changes during storage. Untreated frass showed a progressive decrease in resonances assigned to α- and β-glucose, together with the emergence of signals in the glycerol region con-sistent with fermentation-derived metabolites, including 3-hydroxypropionate and 1,3-propanediol. These spectral changes indicate ongoing microbial metabolism and limited storage stability. Samples treated at 70 °C for 1 h retained carbohydrate reso-nances for longer but still exhibited measurable spectral evolution over time, suggest-ing partial hygienization rather than complete stabilization. By contrast, the 70 °C for 18 h treatment produced the most stable spectral profiles, with minimal changes throughout storage. Overall, these results demonstrate that 1H NMR profiling can serve as a rapid analytical approach to assess thermal hygienization and detect stor-age-related metabolic drift in frass. The method offers a practical way to compare steri-lization strategies and to support the evaluation of microbiological stabilization in frass-based fertilizers under regulatory frameworks.